References
- Centers for Disease Control and Prevention. Genital HPV infection—CDC Fact Sheet. Atlanta, GA, 2014. Retrieved from: http://www.cdc.gov/std/hpv/hpv-factsheet-march-2014.pdf
- Forman D, de Martel C, Lacey CJ, Soerjomataram I, Lortet-Tieulent J, Bruni L, Vignat J, Ferlay J, Bray F, Plummer M, et al. Global burden of human papillomavirus and related diseases. Vaccine 2012; 30 Suppl 5:F12–23; PMID:23199955; http://dx.doi.org/10.1016/j.vaccine.2012.07.055
- Centers for Disease Control Prevention. FDA licensure of bivalent human papillomavirus vaccine (HPV2, Cervarix) for use in females and updated HPV vaccination recommendations from the Advisory Committee on Immunization Practices (ACIP). MMWR Morb Mortal Wkly Rep 2010; 59:626–9; PMID:20508593.
- Centers for Disease Control and Prevention. HPV vaccine information for clinicians—Fact sheet. Atlanta, GA 2012. Retrieved from: http://www.cdc.gov/std/hpv/stdfact-hpv-vaccine-hcp.htm
- United States Food and Drug Administration. FDA approves Gardasil 9 for prevention of certain cancers caused by five additional types of HPV. 2014; Retrieved from: http://www.fda.gov/NewsEvents/ Newsroom/PressAnnouncements/ucm426485.htm
- Stokley S, Jeyarajah J, Yankey D, Cano M, Gee J, Roark J, Curtis RD, Markowitx L. Human papillomavirus vaccination coverage among adolescents, 2007-2013, and post-licensure vaccine safety monitoring, 2006-2014 - United States. MMWR Morb Mortal Wkly Rep. 2014; 63: 620–624; PMID:25055185.
- Wigle J, Fontenot H, Zimet G. Global delivery of human papillomavirus vaccines. Pediatr Clin North Am 2016; 63:81–95; PMID:26613690; http://dx.doi.org/10.1016/j.pcl.2015.08.004
- Reagan-Steiner S, Yankey D, Jeyarajah J, Elam-Evans LD, Singleton JA, Curtis CR, MacNeil J, Markowitz LE, Stokley S. National, regional, state, and selected local area vaccination coverage among adolescents aged 13–17 years—United States, 2014. MMWR Morb Mortal Wkly Rep; 64:784–92; http://dx.doi.org/10.15585/mmwr.mm6429a3
- United States Department of Health and Human Services. HPV (Human Papillomavirus) vaccine. 2015; Retrieved from: http://www.vaccines.gov/diseases/hpv/
- Dempsey AF, Davis MM. Overcoming barriers to adherence to HPV vaccination recommendations. Am J Manag Care 2006; 12:S484–91; PMID:17203992.
- Wilde GJ. Risk homeostasis theory: an overview. Inj Prev 1998; 4:89–91; PMID:9666358; http://dx.doi.org/10.1136/ip.4.2.89
- Pollitt K. Virginity or death! The Nation. New York, NY: Nation Co Inc 33 Irving Place, 8th Floor, New York, NY 10003 USA, 2005.
- Guichon JR, Mitchell I, Buffler P, Caplan A. Citizen intervention in a religious ban on in-school HPV vaccine administration in Calgary, Canada. Prev Med 2013; 57:409–13; PMID:23769899; http://dx.doi.org/10.1016/j.ypmed.2013.06.005
- HPV vaccine not as effective as abstinence, B.C. bishop tells parents. CBC News. Sep 24, 2015. Retrieved from: http://www.cbc.ca/news/canada/british-columbia/hpv-vaccine-abstinence-bishop-bc-1.3242076
- Smith R, Motiuk D, Henry F, Pettipas G, Bouchard L, Chatlain M. A message to Catholic parents/ guardians and the Catholic educational community 2008. Available:http://ccsdmedia.s3.amazonaws.com/wp-content/uploads/2014/08/Alberta_Bishops_letter.pdf
- Waller J, Marlow LA, Wardle J. Mothers’ attitudes towards preventing cervical cancer through human papillomavirus vaccination: a qualitative study. Cancer Epidemiol Biomarkers Prev 2006; 15:1257–61; PMID:16835320; http://dx.doi.org/10.1158/1055-9965.EPI-06-0041
- Brewer NT, Fazekas KI. Predictors of HPV vaccine acceptability: a theory-informed, systematic review. Prev Med 2007; 45:107–14; PMID:17628649; http://dx.doi.org/10.1016/j.ypmed.2007.05.013
- Friedman AL, Shepeard H. Exploring the knowledge, attitudes, beliefs, and communication preferences of the general public regarding HPV findings from CDC focus group research and implications for practice. Health Educ Behav 2007; 34:471–85; PMID:17000622; http://dx.doi.org/10.1177/1090198106292022
- Olshen E, Woods ER, Austin SB, Luskin M, Bauchner H. Parental acceptance of the human papillomavirus vaccine. J Adolesc Health 2005; 37:248–51; PMID:16109349; http://dx.doi.org/10.1016/j. jadohealth.2005.05.016
- Habel MA, Liddon N, Stryker JE. The HPV vaccine: a content analysis of online news stories. J Womens Health 2009; 18:401–7; http://dx.doi.org/10.1089/jwh.2008.0920
- Rosenthal D, Dyson S, Pitts M, Garland S. Challenges to accepting a human papilloma virus (HPV) vaccine: a qualitative study of Australian women. Women & Health 2007; 45:59–73; PMID:18019286; http://dx.doi.org/10.1300/J013v45n02_04
- Mayer MK, Reiter PL, Zucker RA, Brewer NT. Parents’ and sons’ beliefs in sexual disinhibition after human papillomavirus vaccination. Sex Transm Dis 2013; 40:822–8; PMID:24275737; http://dx.doi. org/10.1097/OLQ.0000000000000021
- Ogilvie GS, Remple VP, Marra F, McNeil SA, Naus M, Pielak KL, Ehlen TG, Dobson SR, Money DM, Patrick DM. Parental intention to have daughters receive the human papillomavirus vaccine. Can Med Assoc J 2007; 177:1506–12; http://dx.doi.org/10.1503/cmaj.071022
- Schuler CL, Reiter PL, Smith JS, Brewer NT. Human papillomavirus vaccine and behavioural disinhibition. Sex Transm Infect 2011; 87:349–353; PMID:21357601; http://dx.doi.org/10.1136/sti.2010.048017
- Marlow LAV, Forster AS, Wardle J, Waller J. Mothers’ and adolescents’ beliefs about risk compensation following HPV vaccination. J Adolesc Health 2009; 44:446–51; PMID:19380091; http://dx.doi.org/10.1016/j.jadohealth.2008.09.011
- Brabin L, Roberts SA, Stretch R, Baxter D, Chambers G, Kitchener H, McCann R. Uptake of first two doses of human papillomavirus vaccine by adolescent schoolgirls in Manchester: prospective cohort study. BMJ 2008; 336:1056–8; PMID:18436917; http://dx.doi.org/10.1136/bmj.39541.534109.BE
- Etter DJ, Zimet GD, Rickert VI. Human papillomavirus vaccine in adolescent women: a 2012 update. Curr Opin Obstet Gynecol 2012; 24:305–10; PMID:22781077; http://dx.doi.org/10.1097/ GCO.0b013e3283567005
- Aujo JC, Bakeera-Kitaka S, Kiguli S, Mirembe F. No difference in sexual behavior of adolescent girls following Human Papilloma Virus vaccination: a case study two districts in Uganda; Nakasongola and Luwero. BMC Public Health 2014; 14:155; PMID:24520841; http://dx.doi.org/10.1186/1471-2458-14-155
- Marchand E, Glenn B, Bastani R. HPV vaccination and sexual behavior in a community college sample. J Commun Health 2013; 38:1010–4; http://dx.doi.org/10.1007/s10900-013-9710-0
- Mattebo M, Grun N, Rosenblad A, Larsson M, Haggstrom-Nordin E, Dalianis T, Tyden T. Sexual experiences in relation to HPV vaccination status in female high school students in Sweden Eur J Contracept Reprod Health Care 2014; 19:86–92; PMID:24555926; http://dx.doi.org/10.3109/13625187.2013.878021
- Mayhew A, Mullins TL, Ding L, Rosenthal SL, Zimet GD, Morrow C, Kahn JA. Risk perceptions and subsequent sexual behaviors after HPV vaccination in adolescents. Pediatrics 2014; 133:404–11; PMID:24488747; http://dx.doi.org/10.1542/peds.2013-2822
- Mather T, McCaffery K, Juraskova I. Does HPV vaccination affect women's attitudes to cervical cancer screening and safe sexual behaviour? Vaccine 2012; 30:3196–201; PMID:22425789; http://dx.doi.org/10.1016/j.vaccine.2012.02.081
- Ruiz-Sternberg AM, Pinzon-Rondon AM. Risk perception and sexual behavior in HPV-vaccinated and unvaccinated young Colombian women. Int J Gynaecol Obstet 2014; 126:205–8; PMID:24996685; http://dx.doi.org/10.1016/j.ijgo.2014.03.033
- Gilkey MB, Malo TL, Shah PD, Hall ME, Brewer NT. Quality of physician communication about Human Papillomavirus vaccine: Findings from a national survey. Cancer Epidemiol Biomarkers Prev 2015; 24:1673–9; PMID:26494764; http://dx.doi.org/10.1158/1055-9965.EPI-15-0326
- Zimet GD, Stupiansky NW, Weiss TW, Rosenthal SL, Good MB, Vichnin MD. Influence of patient's relationship status and HPV history on physicians’ decisions to recommend HPV vaccination. Vaccine 2011; 29:378–81; PMID:21111781; http://dx.doi.org/10.1016/j.vaccine.2010.11.027
- Kepka D, Berkowitz Z, Yabroff KR, Roland K, Saraiya M. Human papillomavirus vaccine practices in the USA: do primary care providers use sexual history and cervical cancer screening results to make HPV vaccine recommendations? Sex Transm Infect 2012; 88:433–5; PMID:22522751; http://dx.doi.org/10.1136/sextrans-2011-050437
- Forster AS, Marlow LA, Stephenson J, Wardle J, Waller J. Human papillomavirus vaccination and sexual behaviour: cross-sectional and longitudinal surveys conducted in England. Vaccine 2012; 30:4939–44; PMID:22664223; http://dx.doi.org/10.1016/j.vaccine.2012.05.053
- Hansen BT, Kjaer SK, Arnheim-Dahlstrom L, Liaw KL, Jensen KE, Thomsen LT, Munk C, Nygard M. Human papillomavirus (HPV) vaccination and subsequent sexual behaviour: evidence from a large survey of Nordic women. Vaccine 2014; 32:4945–53; PMID:25045810; http://dx.doi.org/10.1016/j.vaccine.2014.07.025
- Liddon NC, Leichliter JS, Markowitz LE. Human Papillomavirus vaccine and sexual behavior among adolescent and young women. Am J Prev Med 2012; 42:44–52; PMID:22176845; http://dx.doi.org/ 10.1016/j.amepre.2011.09.024
- Lutringer-Magnin D, Kalecinski J, Cropet C, Barone G, Ronin V, Regnier V, Leocmach Y, Jacquard AC, Vanhems P, Chauvin F, et al. Prevention of sexually transmitted infections among girls and young women in relation to their HPV vaccination status. Eur J Public Health 2013; 23:1046–53; PMID:23430762; http://dx.doi.org/10.1093/eurpub/ckt018
- Cummings T, Zimet GD, Brown D, Tu W, Yang Z, Fortenberry JD, Shew ML. Reduction of HPV infections through vaccination among at-risk urban adolescents. Vaccine 2012; 30:5496–9; PMID:22750043; http://dx.doi.org/10.1016/j.vaccine.2012.06.057
- Al Romaih WRR, Srinivas A, Shahtahmasebi S, Omar HA. No significant change in sexual behavior in association with human papillomavirus vaccination in young girls. Int J Child Adolesc Health 2011; 4:351–5.
- Brown B, Blas MM, Heidari O, Carcamo C, Halsey NA. Reported changes in sexual behaviour and human papillomavirus knowledge in Peruvian female sex workers following participation in a human papillomavirus vaccine trial. Int J STD AIDS 2013; 24:531–5; PMID:23970767; http://dx.doi.org/10.1177/0956462412473891
- Ratanasiripong NT. Human papillomavirus vaccine increases high-risk sexual behaviors: a myth or valid concern. J Sch Nurs 2014; 30:456–63; PMID:24414172; http://dx.doi.org/10.1177/ 1059840513520042
- Rysavy MB, Kresowik JD, Liu D, Mains L, Lessard M, Ryan GL. Human papillomavirus vaccination and sexual behavior in young women. J Pediatr Adolesc Gynecol 2014; 27:67–71; PMID:24405635; http://dx.doi.org/10.1016/j.jpag.2013.08.009
- Sadler L, Roberts SA, Hampal G, McManus D, Mandal D, Brabin L. Comparing risk behaviours of human papillomavirus-vaccinated and non-vaccinated women. J Fam Plann Reprod Health Care 2015; PMID:25605479.
- Ports KA, Barnack-Tavlaris JL, Mosavel M, Murithi LK. Young women's sexual and reproductive health post HPV vaccination. Womens Reprod Health 2014; 1:43–55; http://dx.doi.org/10.1080/ 23293691.2014.901804
- Sadler L, Roberts SA, Hampal G, McManus D, Mandal D, Brabin L. Comparing risk behaviours of human papillomavirus-vaccinated and non-vaccinated women. J Fam Plann Reprod Health Care 2015; 41:255–8; PMID:25605479; http://dx.doi.org/10.1136/jfprhc-2014-100896
- Bednarczyk RA, Davis R, Ault K, Orenstein W, Omer SB. Sexual activity–related outcomes after human papillomavirus vaccination of 11-to 12-year-olds. Pediatrics 2012; 130:798–805; PMID:23071201; http://dx.doi.org/10.1542/peds.2012-1516
- Fonseca-Moutinho JA. Smoking and cervical cancer. ISRN obstetrics and gynecology 2011; 2011:847684; PMID:21785734; http://dx.doi.org/10.5402/2011/847684
- International Agency for Research on Cancer. Tobacco smoke and involuntary smoking. IARC monographs on the evaluation of carcinogenic risks to humans / World Health Organization, International Agency for Research on Cancer 2004; 83:1–1438.
- Jena AB, Goldman DP, Seabury SA. Incidence of sexually transmitted infections after human papillomavirus vaccination among adolescent females. JAMA Int Med 2015; 175:617–23; http://dx.doi.org/10.1001/jamainternmed.2014.7886
- Smith LM, Kaufman JS, Strumpf EC, Levesque LE. Effect of human papillomavirus (HPV) vaccination on clinical indicators of sexual behaviour among adolescent girls: the Ontario Grade 8 HPV Vaccine Cohort Study. Can Med Assoc J 2015; 187:E74–81; http://dx.doi.org/10.1503/cmaj.140900
- Fortenberry JD, Costa FM, Jessor R, Donovan JE. Contraceptive behavior and adolescent lifestyles: A structural modeling approach. J Res Adolesc 1997; 7:307–29; PMID:12292602; http://dx.doi.org/10.1207/s15327795jra0703_4
- Kahn JA, Xu J, Zimet GD, Liu N, Gonin R, Dillard ME, Squires K. Risk perceptions after Human Papillomavirus Vaccination in HIV-infected adolescents and young adult women. J Adolesc Health 2012; 50:464–70; PMID:22525109; http://dx.doi.org/10.1016/j.jadohealth.2011.09.005
- Mullins TL, Zimet GD, Rosenthal SL, Morrow C, Ding L, Shew M, Fortenberry JD, Bernstein DI, Kahn JA. Adolescent perceptions of risk and need for safer sexual behaviors after first human papillomavirus vaccination. Arch Pediatr Adolesc Med 2012; 166:82–8; PMID:22213755; http://dx.doi.org/10.1001/archpediatrics.2011.186
- Mullins TLK, Widdice LE, Rosenthal SL, Zimet GD, Kahn JA. Risk perceptions, sexual attitudes, and sexual behavior after HPV vaccination in 11–12 year-old girls. Vaccine 2015; 33:3907–12; PMID:26116249; http://dx.doi.org/10.1016/j.vaccine.2015.06.060
- Zimet GD, Rosberger Z, Fisher WA, Perez S, Stupiansky NW. Beliefs, behaviors and HPV vaccine: Correcting the myths and the misinformation. Prev Med 2013; 57:414–8; PMID:23732252; http://dx.doi.org/10.1016/j.ypmed.2013.05.013
- Coles VA, Patel AS, Allen FL, Keeping ST, Carroll SM. The association of human papillomavirus vaccination with sexual behaviours and human papillomavirus knowledge: a systematic review. Int J STD AIDS 2014:777–88; PMID:25300588.
- Hunsaker J, Veselovskiy G, Gazmararian JA. Health insurance plans and immunization: assessment of practices and policies, 2005-2008. Pediatrics 2009; 124 Suppl 5:S532–9; PMID:19948585; http://dx.doi.org/10.1542/peds.2009-1542M
- Markowitz LE, Dunne E, Saraiya M, Lawson H, Chesson H, Unger E. Quadrivalent human papillomavirus vaccine. MMWR Morb Mortal Wkly Rep 2007; 56:1–24; PMID:17218934.
- Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. J Clin Epidemiol 2009; 62:1006–12; PMID:19631508; http://dx.doi.org/10.1016/j.jclinepi.2009.06.005
- Higgins JP, Green S. Cochrane handbook for systematic reviews of interventions. Wiley Online Library, 2008.
- West S, King V, Carey TS, Lohr KN, McKoy N, Sutton SF, Lux L. Systems to rate the strength of scientific evidence. Evid Rep Technol Assess (Summ) 2002:1–11; PMID:11979732.
- National Institutes of Health. Quality assessment tool for observational cohort and cross-sectional studies. 2014. Available: https://www.nhlbi.nih.gov/health-pro/guidelines/in-develop/cardiovascularrisk-reduction/tools/cohort